EVALUATION OF LOWER GASTROINTESTINAL BLEEDING RISK ASSOCIATED WITH USE OF LOW DOSE ASPIRIN

MF AZIZ; AR KHAN; A BASHIR

doi:10.54112/bcsrj.v2022i1.145

Authors

MF AZIZ Department of Medicine, Nishtar Medical University & Hospital Multan
AR KHAN Department of Medicine, Nishtar Medical University & Hospital Multan
A BASHIR Department of Medicine, Nishtar Medical University & Hospital Multan

DOI:

https://doi.org/10.54112/bcsrj.v2022i1.145

Keywords:

Low dose aspirin, extracranial bleeding, gastrointestinal bleeding

Abstract

To evaluate risk of aspirin related lower gastrointestinal bleeding a Prospective study was performed at Department of medicine, Nishtar Hospital, Multan from July 2019 to January 2020. Total 372 patients using low dose aspirin were selected from out-patient department of Medicine. All patients underwent diagnostic laboratory test for stool examination. A consultant pathologist confirmed presence or absence of lower gastrointestinal bleeding. Data including age, gender, history of bleeding per rectum, blood on stools, BMI, duration of aspirin use, and reason for aspirin prescription was recorded. The study was conducted on 372 patients, 120 (32.3%) were female while 252 (67.7 %) were male. Mean age of the patients was 40 years. Mean duration of use of low dose aspirin was 22.23 ± 16.59 months. Lower gastrointestinal bleeding was noted in 81 (21.8%). Use of dose aspirin is significantly associated with lower gastrointestinal bleeding. Clinicians must anticipate adverse effects in such patients.

Downloads

Download data is not yet available.

References

Ahmed, J., Alam, L., Shabbir, K., Naqvi, M., Haider, E., and Farooque, A. (2020). ENDOSCOPIC FINDINGS IN PATIENTS PRESENTING WITH UPPER GI BLEED IN A TERTIARY CARE FACILITY. Pakistan Armed Forces Medical Journal, 112.

Chen, W. C., Lin, K. H., Huang, Y. T., Tsai, T. J., Sun, W. C., Chuah, S. K., Wu, D. C., and Hsu, P. I. (2017). The risk of lower gastrointestinal bleeding in low‐dose aspirin users. Alimentary Pharmacology & Therapeutics45, 1542-1550.

Dasa, O., Pepine, C. J., and Pearson, T. A. (2021). Aspirin in primary prevention: what changed? A critical appraisal of current evidence. The American journal of cardiology141, 38-48.

e Hina, R., Mansoor, H., Bilal, K., Asghar, A., Ullah, M. A. S., and Zahid, T. R. (2021). Variceal Hemorrhage as the Commonest Cause of Presentation with Acute Upper Gastrointestinal Bleeding: A Paradigm Shift. Annals of Punjab Medical College (APMC)15, 195-198.

Garcia Rodriguez, L. A., Lanas, A., Soriano-Gabarró, M., and Cea Soriano, L. (2019). Low-dose aspirin and risk of upper/lower gastrointestinal bleeding by bleed severity: a cohort study with nested case-control analysis using primary care electronic health records from the United Kingdom. Annals of medicine51, 182-192.

García Rodríguez, L. A., Martín-Pérez, M., Hennekens, C. H., Rothwell, P. M., and Lanas, A. (2016). Bleeding risk with long-term low-dose aspirin: a systematic review of observational studies. PloS one11, e0160046.

Hreinsson, J. P., Gumundsson, S., Kalaitzakis, E., and Björnsson, E. S. (2013). Lower gastrointestinal bleeding: incidence, etiology, and outcomes in a population-based setting. European journal of gastroenterology & hepatology25, 37-43.

Joseph, P., Roshandel, G., Gao, P., Pais, P., Lonn, E., Xavier, D., Avezum, A., Zhu, J., Liu, L., and Sliwa, K. (2021). Fixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysis. The Lancet398, 1133-1146.

Knowles, R. B., and Warner, T. D. (2019). Anti-platelet drugs and their necessary interaction with endothelial mediators and platelet cyclic nucleotides for therapeutic efficacy. Pharmacology & therapeutics193, 83-90.

Lanas, Á., Carrera-Lasfuentes, P., Arguedas, Y., García, S., Bujanda, L., Calvet, X., Ponce, J., Perez-Aísa, Á., Castro, M., and Muñoz, M. (2015). Risk of upper and lower gastrointestinal bleeding in patients taking nonsteroidal anti-inflammatory drugs, antiplatelet agents, or anticoagulants. Clinical Gastroenterology and Hepatology13, 906-912. e2.

Sugawara, M., Goto, Y., Yamazaki, T., Teramoto, T., Oikawa, S., Shimada, K., Uchiyama, S., Ando, K., Ishizuka, N., and Murata, M. (2019). Low-dose aspirin for primary prevention of cardiovascular events in elderly Japanese patients with atherosclerotic risk factors: subanalysis of a randomized clinical trial (JPPP-70). American Journal of Cardiovascular Drugs19, 299-311.

Wang, Y., Wang, W., Wang, B., and Wang, Y. (2020). The risk of gastrointestinal hemorrhage in low-dose aspirin users with diabetes mellitus: systematic review and meta-analysis. Gastroenterology research and practice2020.

Whitlock, E. P., Burda, B. U., Williams, S. B., Guirguis-Blake, J. M., and Evans, C. V. (2016). Bleeding risks with aspirin use for primary prevention in adults: a systematic review for the US Preventive Services Task Force. Annals of internal medicine164, 826-835.

Zhang, J., Huang, J., Zhao, Y., and Zhang, W. (2022). The preventive effects of aspirin on preeclampsia based on network pharmacology and bioinformatics. Journal of Human Hypertension36, 753-759.

Zheng, S. L., and Roddick, A. J. (2019). Association of aspirin use for primary prevention with cardiovascular events and bleeding events: a systematic review and meta-analysis. Jama321, 277-287.

Zia, N., Alam, L., and Ashraf, N. (2021). ENDOSCOPIC FINDING IN PATIENTS PRESENTING WITH LOWER GASTROINTESTINAL BLEED-A STUDY FROM A DEVELOPING COUNTRY. Pakistan Armed Forces Medical Journal, 215.